|

Allogeneic Human E-islet (E-islet 01) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • EndoCell Therapeutics, Inc.1

Indications

  • Severe Hypoglycemia1
  • Impaired Hypoglycemic Awareness1
  • Diabetes Mellitus, Type 11
  • Diabetes1

Other1 trial

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.